Novel strategies and therapeutic options for the management of primary biliary cholangitis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2017, v. 10, n. 10, p. 791, doi. 10.1177/1756283X17728669
- By:
- Publication type:
- Article
Works matching IS 1756283X AND DT 2017 AND VI 10 AND IP 10
Results: 5
1
2
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges.
- Published in:
- Therapeutic Advances in Gastroenterology, 2017, v. 10, n. 10, p. 773, doi. 10.1177/1756283X17727388
- By:
- Publication type:
- Article
3
Increased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Gastroenterology, 2017, v. 10, n. 10, p. 761, doi. 10.1177/1756283X17725998
- By:
- Publication type:
- Article
4
The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine.
- Published in:
- Therapeutic Advances in Gastroenterology, 2017, v. 10, n. 10, p. 749, doi. 10.1177/1756283X17722926
- By:
- Publication type:
- Article
5
Current immunotherapeutic strategies in hepatocellular carcinoma: recent advances and future directions.
- Published in:
- Therapeutic Advances in Gastroenterology, 2017, v. 10, n. 10, p. 805, doi. 10.1177/1756283X17722061
- By:
- Publication type:
- Article